Dr. Feng Liu is currently an assistant professor in the Department of Systems Engineering here at Stevens, and his latest project is making and developing AI models that help “decode” the brain with ...

Early Alzheimer’s marker, phosphorylated tau protein (pTau), doesn’t just stay in the brain. Its presence in the heart and kidneys could transform diagnostics.

When Robert F. Kennedy Jr., the U.S. Secretary of Health and Human Services, was reportedly spotted using a nicotine pouch during his Senate confirmation hearing, it sparked a firestorm of curiosity.

Researchers identified a blood immune signature linked to amyloid-related imaging abnormalities in patients receiving Alzheimer’s antibody therapy. The findings may help predict treatment side effects ...

A team of researchers at the USC Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC has identified important differences in how early ...

Neuroscientists have uncovered new insights into a key evolutionary question: Why can humans talk when most animals can't? The journal Science published the research led by Emory University and the ...

Kensington, MD, USA and Munich/Martinsried, Germany, March 12, 2026 (GLOBE NEWSWIRE) -- Galimedix Therapeutics earns milestone payment in ophthalmology partnership with Théa Open Innovation Galimedix ...

Discover how AI healthcare technology and machine learning diagnosis are transforming disease detection, improving accuracy, and reshaping patient care in today's evolving medical landscape.

Most Americans drink coffee or tea every day. Here's how the beverages compare when it comes to health benefits and which to drink for breakfast or any time of day.

Alzheimer’s disease is widely known for its most visible symptoms, such as memory loss, confusion, and difficulty thinking clearly. These changes often appear slowly and become worse over time.

Neuroscientists at King’s College London (UK) have pinpointed a mechanism behind the increased neural connectivity seen in very early stages of Alzheimer’s disease. Published in Translational ...

Summary: For years, Alzheimer’s research has been criticized for lacking diversity, with the majority of studies based on participants of European ancestry. A landmark study has officially shattered ...